CORRECTION

Regulatory changes proposed by Canada's Patented Medicine Prices Review Board scheduled to take effect Jan. 1 have been postponed to July 1, 2021. Incorrect information appeared in Tasha Kheiriddin's column in Wednesday's edition. The Post regrets the error.